Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 70, No 4 (2019)
Review paper
Submitted: 2019-02-12
Accepted: 2019-03-25
Published online: 2019-08-14
View PDF Download PDF file
Get Citation

Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders

Jowita Halupczok-Żyła1, Łukasz Gojny1, Marek Bolanowski1
DOI: 10.5603/EP.a2019.0022
·
Pubmed: 31489959
·
Endokrynol Pol 2019;70(4):350-356.
Affiliations
  1. Department and Clinic of Endocrinology, Diabetes, and Isotope Therapy, Wrocław Medical University, Poland

open access

Vol 70, No 4 (2019)
Review Article
Submitted: 2019-02-12
Accepted: 2019-03-25
Published online: 2019-08-14

Abstract

Trabecular bone score (TBS) index has recently been obtained as a result of textural greyscale analysis of DXA images. Because it enables the assessment of bone microarchitectural texture, TBS may be useful in evaluating bone quality. This study explores the current knowledge of the use of TBS in patients with endocrine disorders with co-occurring bone structure changes. Currently, the clinical importance TBS was verified in terms of disorders of the growth hormone/insulin-like growth factor 1 (GH/IGF-I) axis, glucocorticoid excess, thyroid and parathyroid disease, as well as in diabetes mellitus type 1 and 2.
It has been clarified that patients suffering from various endocrinopathies are a group in which TBS should be used routinely because it correlates with clinical factors and may improve patient management in various endocrine disorders. 

Abstract

Trabecular bone score (TBS) index has recently been obtained as a result of textural greyscale analysis of DXA images. Because it enables the assessment of bone microarchitectural texture, TBS may be useful in evaluating bone quality. This study explores the current knowledge of the use of TBS in patients with endocrine disorders with co-occurring bone structure changes. Currently, the clinical importance TBS was verified in terms of disorders of the growth hormone/insulin-like growth factor 1 (GH/IGF-I) axis, glucocorticoid excess, thyroid and parathyroid disease, as well as in diabetes mellitus type 1 and 2.
It has been clarified that patients suffering from various endocrinopathies are a group in which TBS should be used routinely because it correlates with clinical factors and may improve patient management in various endocrine disorders. 

Full Text:

View PDF Download PDF file
Get Citation

Keywords

osteoporosis; fractures; bone quality

About this article
Title

Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders

Journal

Endokrynologia Polska

Issue

Vol 70, No 4 (2019)

Article type

Review paper

Pages

350-356

Published online

2019-08-14

Page views

2151

Article views/downloads

1908

DOI

10.5603/EP.a2019.0022

Pubmed

31489959

Bibliographic record

Endokrynol Pol 2019;70(4):350-356.

Keywords

osteoporosis
fractures
bone quality

Authors

Jowita Halupczok-Żyła
Łukasz Gojny
Marek Bolanowski

References (61)
  1. Biver E, Durosier-Izart C, Chevalley T, et al. Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women. J Bone Miner Res. 2018; 33(2): 328–337.
    CrossRefPubMed
  2. Shevroja E, Lamy O, Kohlmeier L, et al. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice. J Clin Densitom. 2017; 20: 334–45.
    CrossRefPubMed
  3. Ward RJ, Roberts CC, Bencardino JT, et al. Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria Osteoporosis and Bone Mineral Density. J Am Coll Radiol. 2017; 14(5S): S189–S202.
    CrossRefPubMed
  4. Oei L, Koromani F, Rivadeneira F, et al. Quantitative imaging methods in osteoporosis. Quant Imaging Med Surg. 2016; 6(6): 680–698.
    CrossRefPubMed
  5. Martineau P, Leslie WD. Trabecular bone score (TBS): Method and applications. Bone. 2017; 104: 66–72.
    CrossRefPubMed
  6. Silva BC, Leslie WD. Trabecular Bone Score: A New DXA-Derived Measurement for Fracture Risk Assessment. Endocrinol Metab Clin North Am. 2017; 46(1): 153–180.
    CrossRefPubMed
  7. Seeman E, Delmas PD. Bone quality — the material and structural basis of bone strength and fragility. N Engl J Med. 2006; 354(21): 2250–2261.
    CrossRefPubMed
  8. Leslie WD, Majumdar SR, Morin SN, et al. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort. J Bone Miner Res. 2017; 32(3): 618–623.
    CrossRefPubMed
  9. Martineau P, Leslie WD, Johansson H, et al. Clinical Utility of Using Lumbar Spine Trabecular Bone Score to Adjust Fracture Probability: The Manitoba BMD Cohort. J Bone Miner Res. 2017; 32(7): 1568–1574.
    CrossRefPubMed
  10. Battista C, Chiodini I, Muscarella S, et al. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Clin Endocrinol (Oxf). 2009; 70(3): 378–382.
    CrossRefPubMed
  11. Couraud G, Souffir C, Gaigneux E, et al. Adjusting FRAX® on TBS for identification of subjects at high risk of fractures. Bone. 2017; 101: 214–218.
    CrossRefPubMed
  12. Silva BC, Bilezikian JP. Trabecular bone score: perspectives of an imaging technology coming of age. Arq Bras Endocrinol Metabol. 2014; 58(5): 493–503.
    PubMed
  13. McCloskey EV, Odén A, Harvey NC, et al. Adjusting fracture probability by trabecular bone score. Calcif Tissue Int. 2015; 96(6): 500–509.
    CrossRefPubMed
  14. Leslie WD, Aubry-Rozier B, Lix LM, et al. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program. Bone. 2014; 67: 10–14.
    CrossRefPubMed
  15. Messina C, Poloni A, Chianca V, et al. Increasing soft tissue thickness does not affect trabecular bone score reproducibility: a phantom study. Endocrine. 2018; 61(2): 336–342.
    CrossRefPubMed
  16. Mazziotti G, Biagioli E, Maffezzoni F, et al. Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab. 2015; 100(2): 384–394.
    CrossRefPubMed
  17. Cortet B, Bousson V. TBS and bone strength. Bonekey Rep. 2016; 5: 792.
    CrossRefPubMed
  18. Kim YS, Han JJ, Lee J, et al. The correlation between bone mineral density/trabecular bone score and body mass index, height, and weight. Osteoporos Sarcopenia. 2017; 3(2): 98–103.
    CrossRefPubMed
  19. Roux JP, Wegrzyn J, Boutroy S, et al. The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos Int. 2013; 24(9): 2455–2460.
    CrossRefPubMed
  20. Muschitz C, Kocijan R, Haschka J, et al. TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone. 2015; 79: 259–266.
    CrossRefPubMed
  21. Ayoub ML, Maalouf G, Cortet B, et al. Trabecular Bone Score and Osteoporotic Fractures in Obese Postmenopausal Women. J Clin Densitom. 2016; 19(4): 544–545.
    CrossRefPubMed
  22. De Mingo Dominguez ML, Guadalix Iglesias S, Martin-Arriscado Arroba C, et al. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy. Endocrine. 2018; 62(1): 166–173.
    CrossRefPubMed
  23. Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014; 29(3): 518–530.
    CrossRefPubMed
  24. Winzenrieth R, Michelet F, Hans D. Three-dimensional (3D) microarchitecture correlations with 2D projection image gray-level variations assessed by trabecular bone score using high-resolution computed tomographic acquisitions: effects of resolution and noise. J Clin Densitom. 2013; 16(3): 287–296.
    CrossRefPubMed
  25. Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone. 2008; 42(4): 775–787.
    CrossRefPubMed
  26. Schousboe JT, Vo TN, Langsetmo L, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos Int. 2018; 29(1): 49–59.
    CrossRefPubMed
  27. Bousson V, Bergot C, Sutter B, et al. Scientific Committee of the Groupe de Recherche et d’Information sur les Ostéoporoses. Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects. Osteoporos Int. 2012; 23(5): 1489–1501.
    CrossRefPubMed
  28. Martineau P, Silva BC, Leslie WD. Utility of trabecular bone score in the evaluation of osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2017; 24(6): 402–410.
    CrossRefPubMed
  29. Amnuaywattakorn S, Sritara C, Utamakul C, et al. Simulated increased soft tissue thickness artefactually decreases trabecular bone score: a phantom study. BMC Musculoskelet Disord. 2016; 17: 17.
    CrossRefPubMed
  30. Schousboe JT, Vo TN, Langsetmo L, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Association of Trabecular Bone Score (TBS) With Incident Clinical and Radiographic Vertebral Fractures Adjusted for Lumbar Spine BMD in Older Men: A Prospective Cohort Study. J Bone Miner Res. 2017; 32(7): 1554–1558.
    CrossRefPubMed
  31. Simonelli C, Leib E, Mossman N, et al. Creation of an age-adjusted, dual-energy X-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-Hispanic US White women. J Clin Densitom. 2014; 17(2): 314–319.
    CrossRefPubMed
  32. Kim JH, Choi HJ, Ku EJ, et al. Regional body fat depots differently affect bone microarchitecture in postmenopausal Korean women. Osteoporos Int. 2016; 27(3): 1161–1168.
    CrossRefPubMed
  33. Gromov AA, Il’In AP, Foerter-Barth U, et al. Effect of the passivating coating type, particle size, and storage time on oxidation and nitridation of aluminum powders. Combust Explos Shock Waves. 2006; 42: 177–84.
    CrossRef
  34. Valassi E, Crespo I, Malouf J, et al. Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly. Endocrine. 2016; 53(3): 860–864.
    CrossRefPubMed
  35. Godang K, Olarescu NC, Bollerslev J, et al. Treatment of acromegaly increases BMD but reduces trabecular bone score: a longitudinal study. Eur J Endocrinol. 2016; 175(2): 155–164.
    CrossRefPubMed
  36. Kužma M, Kužmová Z, Zelinková Z, et al. Impact of the growth hormone replacement on bone status in growth hormone deficient adults. Growth Horm IGF Res. 2014; 24(1): 22–28.
    CrossRefPubMed
  37. Allo Miguel G, Serraclara Plá A, Partida Muñoz ML, et al. Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center. Ther Adv Endocrinol Metab. 2016; 7(3): 93–100.
    CrossRefPubMed
  38. Eller-Vainicher C, Filopanti M, Palmieri S, et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol. 2013; 169(2): 155–162.
    CrossRefPubMed
  39. Belaya ZE, Hans D, Rozhinskaya LY, et al. The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome. Arch Osteoporos. 2015; 10: 44.
    CrossRefPubMed
  40. Paggiosi MA, Peel NFA, Eastell R. The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int. 2015; 26(6): 1773–1780.
    CrossRefPubMed
  41. Rizou S, Chronopoulos E, Ballas M, et al. Clinical manifestations of osteoarthritis in osteoporotic and osteopenic postmenopausal women. J Musculoskelet Neuronal Interact. 2018; 18(2): 208–214.
    CrossRefPubMed
  42. Gonzalez Rodriguez E, Lamy O, Stoll D, et al. High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study. J Clin Endocrinol Metab. 2017; 102(7): 2628–2636.
    CrossRefPubMed
  43. Leib ES, Winzenrieth R. Bone status in glucocorticoid-treated men and women. Osteoporos Int. 2016; 27(1): 39–48.
    CrossRefPubMed
  44. Koumakis E, Avouac J, Winzenrieth R, et al. Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposure. J Rheumatol. 2015; 42(2): 228–235.
    CrossRefPubMed
  45. Bréban S, Briot K, Kolta S, et al. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom. 2012; 15(3): 260–266.
    CrossRefPubMed
  46. Eller-Vainicher C, Morelli V, Ulivieri FM, et al. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res. 2012; 27(10): 2223–2230.
    CrossRefPubMed
  47. Romagnoli E, Cipriani C, Nofroni I, et al. "Trabecular Bone Score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone. 2013; 53(1): 154–159.
    CrossRefPubMed
  48. Díaz-Soto G, de Luis Román D, Jauregui OI, et al. Trabecular Bone Score in Patients With Normocalcemic Hyperparathyroidism. Endocr Pract. 2016; 22(6): 703–707.
    CrossRefPubMed
  49. Silva BC, Boutroy S, Zhang C, et al. Trabecular bone score (TBS) — a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013; 98(5): 1963–1970.
    CrossRefPubMed
  50. Walker MD, Saeed I, Lee JA, et al. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Osteoporos Int. 2016; 27(10): 3063–3071.
    CrossRefPubMed
  51. Rolighed L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014; 99(3): 1072–1080.
    CrossRefPubMed
  52. Hwangbo Y, Kim JH, Kim SW, et al. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women. Osteoporos Int. 2016; 27(2): 457–462.
    CrossRefPubMed
  53. De Mingo Dominguez ML, Guadalix Iglesias S, Martin-Arriscado Arroba C, et al. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy. Endocrine. 2018; 62(1): 166–173.
    CrossRefPubMed
  54. Moon JH, Kim KM, Oh TJ, et al. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab. 2017; 102(1): 78–85.
    CrossRefPubMed
  55. Kužma M, Vaňuga P, Binkley N, et al. High Serum Fractalkine is Associated with Lower Trabecular Bone Score in Premenopausal Women with Graves' Disease. Horm Metab Res. 2018; 50(8): 609–614.
    CrossRefPubMed
  56. Poiana C, Capatina C. Fracture Risk Assessment in Patients With Diabetes Mellitus. J Clin Densitom. 2017; 20(3): 432–443.
    CrossRefPubMed
  57. Neumann T, Lodes S, Kästner B, et al. Trabecular bone score in type 1 diabetes — a cross-sectional study. Osteoporos Int. 2016; 27(1): 127–133.
    CrossRefPubMed
  58. Dhaliwal R, Cibula D, Ghosh C, et al. Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int. 2014; 25(7): 1969–1973.
    CrossRefPubMed
  59. Kim JH, Choi HJ, Ku EuJ, et al. Trabecular bone score as an indicator for skeletal deterioration in diabetes. J Clin Endocrinol Metab. 2015; 100(2): 475–482.
    CrossRefPubMed
  60. Leslie WD, Aubry-Rozier B, Lamy O, et al. Manitoba Bone Density Program. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013; 98(2): 602–609.
    CrossRefPubMed
  61. Caffarelli C, Giambelluca A, Ghini V, et al. In Type-2 Diabetes Subjects Trabecular Bone Score is Better Associated with Carotid Intima-Media Thickness than BMD. Calcif Tissue Int. 2017; 101(4): 404–411.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl